DBD vs TECH
Diebold Nixdorf, Incorporated (DBD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the DBD and TECH stock pages for the full models.
Not investment advice.